How a struggling biotech won $1.6 billion to make a coronavirus vaccine

Executives from the Bill & Melinda Gates Foundation, which helped found and finance the nonprofit, were on the line, enthusiastic about Novavax, a small biotech company they thought had the potential to develop a vaccine against the virus -- fast.